title: Prevention of recurrent congenital heart block in a SSA/SSB positive mother using high dose maternal IVIG from 16-week gestation.
authors.affiliation: Maternal and Fetal Medicine Department, John Hunter Hospital, Newcastle, Australia.
authors.forename: Ruth-Ann
authors.identifier: http://orcid.org/0000-0002-7272-8282
authors.initials: RA
authors.lastname: Sterling
authors.affiliation: Maternal and Fetal Medicine Department, John Hunter Hospital, Newcastle, Australia.
authors.forename: Andrew
authors.initials: A
authors.lastname: Carlin
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000276:immunology; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006327:Heart Block / Q000151:congenital* / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000276:immunology; D011262:Pregnancy Trimester, Second; D012008:Recurrence; D012859:Sjogren's Syndrome / Q000188:drug therapy / Q000276:immunology
chemical_list: D000974:Antibodies, Antinuclear; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; C035356:SS-A antibodies; C035357:SS-B antibodies; D003907:Dexamethasone; D011239:Prednisolone